Benzinga | Jul 14, 2020 06:58AM EDT

Oppenheimer Initiates Coverage On Frequency Therapeutics with Outperform Rating, Announces Price Target of $36

Oppenheimer analyst Jay Olson initiates coverage on Frequency Therapeutics (NASDAQ:FREQ) with a Outperform rating and announces Price Target of $36.